Insider · CIK 0001787092

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Reports to the SEC for 16 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001787092

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	10% Owner	CConversion	+181K sh	—	—	180,635
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	10% Owner	CConversion	+420K sh	—	—	600,906
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	10% Owner	CConversion	+201K sh	—	—	801,624
2024-09-16	ZBIOZenas BioPharma, Inc. · Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.57M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−3.65M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.74M sh	—	—	0
2024-07-22	ARTVArtiva Biotherapeutics, Inc.C Conversion	10% Owner	CConversion	+145K sh	—	—	145,089
2024-07-22	ARTVArtiva Biotherapeutics, Inc.J Other	10% Owner	JOther	+49K sh	$10.20	+$500K	194,108
2024-07-22	ARTVArtiva Biotherapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−145K sh	—	—	0
2024-04-02	BOLDBoundless Bio, Inc.C Conversion	10% Owner	CConversion	+190K sh	—	—	189,933
2024-04-02	BOLDBoundless Bio, Inc.C Conversion	10% Owner	CConversion	+366K sh	—	—	556,233
2024-04-02	BOLDBoundless Bio, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−3.7M sh	—	—	0
2024-04-02	BOLDBoundless Bio, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−7.14M sh	—	—	0
2022-11-17	ACRVAcrivon Therapeutics, Inc.C Conversion	10% Owner	CConversion	+888K sh	—	—	888,130
2022-11-17	ACRVAcrivon Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−2.19M sh	—	—	0
2021-08-02	NUVLNuvalent, Inc.C Conversion	10% Owner	CConversion	+898K sh	—	—	897,671
2021-08-02	NUVLNuvalent, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−4.83M sh	—	—	0
2021-06-21	Verve Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.34M sh	—	—	1,343,081
2021-06-21	Verve Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.15M sh	—	—	2,495,571
2021-06-21	Verve Therapeutics, Inc.Series A-2 Preferred StockC Conversion	10% Owner	CConversion	−12.4M sh	—	—	0
2021-06-21	Verve Therapeutics, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−10.7M sh	—	—	0
2021-03-30	EWTXEdgewise Therapeutics, Inc.C Conversion	10% Owner	CConversion	+682K sh	—	—	681,812
2021-03-30	EWTXEdgewise Therapeutics, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−682K sh	—	—	0
2020-11-23	OLMAOlema Pharmaceuticals, Inc.C Conversion	10% Owner	CConversion	+1.27M sh	—	—	1,273,420
2020-11-23	OLMAOlema Pharmaceuticals, Inc.C Conversion	10% Owner	CConversion	+452K sh	—	—	1,725,406
2020-11-23	OLMAOlema Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−1.27M sh	—	—	0
2020-11-23	OLMAOlema Pharmaceuticals, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−452K sh	—	—	0
2020-10-20	ALGSAligos Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.34M sh	—	—	1,335,048
2020-10-20	ALGSAligos Therapeutics, Inc.C Conversion	10% Owner	CConversion	+571K sh	—	—	1,906,191
2020-10-20	ALGSAligos Therapeutics, Inc. · Series B-1 convertible Preferred StockC Conversion	10% Owner	CConversion	−1.34M sh	—	—	0
2020-10-20	ALGSAligos Therapeutics, Inc. · Series B-2 convertible Preferred StockC Conversion	10% Owner	CConversion	−571K sh	—	—	0
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Former 10% Owner	CConversion	+760K sh	—	—	760,267
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series D Preferred StockC Conversion	Former 10% Owner	CConversion	−760K sh	—	—	0
2020-09-21	DYNDyne Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.61M sh	—	—	1,608,785
2020-09-21	DYNDyne Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−5.34M sh	—	—	0
2020-08-25	KYMRKymera Therapeutics, Inc.C Conversion	10% Owner	CConversion	+959K sh	—	—	959,211
2020-08-25	KYMRKymera Therapeutics, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−1.53M sh	—	—	0
2020-07-28	NRIXNurix Therapeutics, Inc.C Conversion	10% Owner	CConversion	+784K sh	—	—	784,313
2020-07-28	NRIXNurix Therapeutics, Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−784K sh	—	—	0
2020-06-23	Forma Therapeutics Holdings, Inc.C Conversion	10% Owner	CConversion	+1.25M sh	—	—	1,252,913
2020-06-23	Forma Therapeutics Holdings, Inc.P Purchase	10% Owner	PPurchase	+1M sh	$20.00	+$20M	2,252,913
2020-06-23	Forma Therapeutics Holdings, Inc.Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−5.36M sh	—	—	0
2020-06-16	GBIOGeneration Bio Co.C Conversion	10% Owner	CConversion	+1.01M sh	—	—	1,012,546
2020-06-16	GBIOGeneration Bio Co.P Purchase	10% Owner	PPurchase	+1.1M sh	$19.00	+$20.9M	2,112,546
2020-06-16	GBIOGeneration Bio Co. · Series C Preferred StockC Conversion	10% Owner	CConversion	−1.79M sh	—	—	0
2020-02-03	BDTXBlack Diamond Therapeutics, Inc.C Conversion	10% Owner	CConversion	+568K sh	—	—	568,185
2020-02-03	BDTXBlack Diamond Therapeutics, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−1.71M sh	—	—	0

Recent filings

Accepted (ET)
Sep 184
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.0001104659-24-101030
SEC(opens sec.gov)
Jul 224
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.0001415889-24-019908
SEC(opens sec.gov)
Apr 24
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.0001415889-24-009885
SEC(opens sec.gov)
Nov 214
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.0000950170-22-025513
SEC(opens sec.gov)
Aug 34
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.0000899243-21-031393
SEC(opens sec.gov)
Jun 224
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.0000899243-21-025303
SEC(opens sec.gov)

Companies

Address

C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET

BOSTON, MA, 02210